Amyotrophic lateral sclerosis (ALS) is a devastating human neurodegenerative disease. The causes of ALS are poorly understood, although the protein TDP-43 has been suggested to play a critical role in disease pathogenesis. Here we show that Ataxin-2, a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2 (SCA2), is a potent modifier of TDP-43 toxicity in animal and cellular models. The proteins associate in a complex that depends on RNA. Ataxin-2 is abnormally localized in spinal cord neurons of ALS patients. Likewise, TDP-43 shows mislocalization in SCA2. To assess a role in ALS, we analyzed the Ataxin-2 gene (ATXN2) in 915 ALS patients. We found intermediate-length polyQ expansions (27–33 Qs) in ATXN2 significantly associated with ALS. These data establish ATXN2 as a relatively common ALS disease susceptibility gene. Further, these findings indicate that the TDP-43/Ataxin-2 interaction may be a promising target for therapeutic intervention in ALS and other TDP-43 proteinopathies.
A search forνµ →νe oscillations has been conducted at the Los Alamos Meson Physics Facility by usingνµ from µ + decay at rest. Theνe are detected via the reactionνe p → e + n, correlated with a γ from np → dγ (2.2 MeV). The use of tight cuts to identify e + events with correlated γ rays yields 22 events with e + energy between 36 and 60 MeV and only 4.6 ± 0.6 background events. A fit to the e + events between 20 and 60 MeV yields a total excess of 51.8 +18.7 −16.9 ± 8.0 events. If attributed toνµ →νe oscillations, this corresponds to an oscillation probability of (0.31 +0.11 −0.10 ± 0.05)%. 14.60. Pq, 13.15.+g We present the results from a search for neutrino oscillations using the Liquid Scintillator Neutrino Detector (LSND) apparatus described in reference [1]. The existence of neutrino oscillations would imply that neutrinos have mass and that there is mixing among the different flavors of neutrinos. Candidate events in a search for the transformationν µ →ν e from neutrino oscillations with the LSND detector have previously been reported [2] for data taken in 1993 and 1994. Data taken in 1995 have been included in this paper, and the analysis has been made more efficient.Protons are accelerated by the LAMPF linac to 800 MeV kinetic energy and pass through a series of targets, culminating with the A6 beam stop. The primary neutrino flux comes from π + produced in a 30-cm-long water target in the A6 beam stop [1]. The total charge delivered to the beam stop while the detector recorded data was 1787 C in 1993, 5904 C in 1994, and 7081 C in 1995. Most of the π + come to rest and decay through the sequence π + → µ + ν µ , followed by µ + → e + ν eνµ , supplyingν µ with a maximum energy of 52.8 MeV. The energy dependence of theν µ flux from decay at rest (DAR) is very well known, and the absolute value is known to 7% [1,3]. The open space around the target is short compared to the pion decay length, so only 3% of the π + decay in flight (DIF). A much smaller fraction (approximately 0.001%) of the muons DIF, due to the difference in lifetimes and that a π + must first DIF. The totalν µ flux averaged over the detector volume, including contributions from upstream targets and all elements of the beam stop, was 7.6 × 10 −10ν µ /cm 2 /proton. Aν e component in the beam comes from the symmetrical decay chain starting with a π − . This background is suppressed by three factors in this experiment. First, π + production is about eight times the π − production in the beam stop. Second, 95% of π − will come to rest and are absorbed before decay in the beam stop. Third, 88% of µ − from π − DIF are captured from atomic orbit, a process which does not give aν e . Thus, the relative yield, compared to the positive channel, is estimated to be ∼ (1/8) × 0.05 × 0.12 = 7.5 × 10 −4 . A detailed Monte Carlo simulation [3], gives a value of 7.8 × 10 −4 for the flux ratio ofν e toν µ .The detector is a tank filled with 167 metric tons of dilute liquid scintillator, located about 30 m from the neutrino source, and surrounded on all s...
The high frequency of carriers of mutations in GJB2 (4.76 percent) predicts a prevalence of 1 deaf person among 1765 people, which may account for the majority of cases of nonsyndromic recessive deafness in the Ashkenazi Jewish population. Conservation of the haplotype flanking the 167delT mutation suggests that this allele has a single origin, whereas the multiple haplotypes with the 30delG mutation suggest that this site is a hot spot for recurrent mutations.
Rapid phagocytic clearance of apoptotic cells is crucial for the prevention of both inflammation and autoimmune responses. Phosphatidylserine (PS) at the external surface of the plasma membrane has been proposed to function as a general 'eat me' signal for apoptotic cells. Although several soluble bridging molecules have been suggested for the recognition of PS, the PS-specific membrane receptor that binds directly to the exposed PS and provides a tickling signal has yet to be definitively identified. In this study, we provide evidence that stabilin-2 is a novel PS receptor, which performs a key function in the rapid clearance of cell corpses. It recognizes PS on aged red blood cells and apoptotic cells, and mediates their engulfment. The downregulation of stabilin-2 expression in macrophages significantly inhibits phagocytosis, and anti-stabilin-2 monoclonal antibody provokes the release of the anti-inflammatory cytokine, transforming growth factor-b. Furthermore, the results of timelapse video analyses indicate that stabilin-2 performs a crucial function in the rapid clearance of aged and apoptotic cells. These data indicate that stabilin-2 is the first of the membrane PS receptors to provide tethering and tickling signals, and may also be involved in the resolution of inflammation and the prevention of autoimmunity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.